Described herein are isolated polypeptides having phosphatase and tensin homolog (PTEN) inhibitory activity, vectors and cells for the expression thereof and methods for their use in treating diseases associated with cytotoxic stress, such as spinal cord injury, stroke, traumatic brain injury, multiple sclerosis, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Huntington's disease.

Wang; Yu Tian

Zhang; Shu

Taghibiglou; Changiz

THE UNIVERSITY OF BRITISH COLUMBIA

Inhibitors of phosphatase and tensin homolog (PTEN) conjugates

The University of British Columbia

Inhibitors of phosphatase and tensin homolog (PTEN) compositions, uses and methods

Novel phosphotetrahydropyran compounds that mimic mannose-6-phosphate but that are more resistant to phosphatases and mannosidases, and pharmaceutical compositions thereof, are disclosed. These compounds and compositions inhibit T lymphocyte migration from blood to tissues or to other extravascular sites. By inhibiting such migration, these compounds are useful for treating diseases or disorders that are mediated at least in part by such T lymphocyte migration. Such diseases and disorders include rheumatoid arthritis, multiple sclerosis, acute disseminated encephalomyelitis, psoriasis, inflammatory bowel disease, T cell-mediated dermatitis, stromal keratitis, uveitis, thyroiditis, sialitis and type I diabetes.

Pharmaxis Pty Limited

Mannose-6-phosphonate compounds for the treatment of inflammatory diseases

sclerosis

phosphatase

sclerosis/phosphatase

Inhibitors of phosphatase and tensin homolog (PTEN) conjugates

Inhibitors of phosphatase and tensin homolog (PTEN) compositions, uses and methods

Mannose-6-phosphonate compounds for the treatment of inflammatory diseases

Najkompletnija baza ljekovitog bilja potpomognuta znanošću